Biomedical industry consists of biotechnology industry and pharmaceutical industry***.
(I) Biotechnology Industry
At present, the definition and scope of biotechnology industry by various countries and organizations are very inconsistent, and even the viewpoints of different people are often very different. This paper adopts the viewpoints of relevant scholars and defines the modern biotechnology industry as follows: biotechnology is a comprehensive technology system based on the theory of modern life sciences, which utilizes living organisms and their cellular, subcellular and molecular components, and combines the means of engineering and informatics to carry out researches and manufacture products, or to transform animals, plants and microorganisms, etc., and to make them have the desired qualities and characteristics, and then to provide the society with commodities and services. It is a comprehensive technological system of means. Its main contents include: genetic engineering, cell engineering, fermentation engineering, enzyme engineering, biochip technology, gene sequencing technology, tissue engineering technology, bioinformation technology and so on. Biotechnology industry involves many fields such as medicine, agriculture, ocean, environment, energy, chemical industry and so on. The application of biotechnology to produce corresponding commodities, such commodities in the market to form a certain scale before the formation of industry, therefore, the connotation of biotechnology industry should include biotechnology product development, large-scale production and distribution services.
(2) Pharmaceutical Industry
Pharmaceutical industry and biomedical engineering industry are the two pillars of modern pharmaceutical industry.
1. Pharmaceutical Industry
Pharmaceutical is the process of researching, developing and producing medicines by combining multidisciplinary theories and advanced technologies with each other, and adopting scientific and modernized mode. In addition to biopharmaceuticals, chemical and traditional Chinese medicines also occupy a certain proportion in the pharmaceutical industry.
2. Biomedical engineering industry
Biomedical engineering is a comprehensive application of life sciences and engineering science principles and methods, from the engineering point of view of molecules, cells, tissues, organs and even the entire human body system, multi-level understanding of the structure of the human body, function and other phenomena of life, the study of the artificial materials used for the prevention and treatment of disease, the human body's functional assistance and health care, products, devices and systems technology. The general name of the technology of artificial materials, products, devices and systems. Biomedical engineering industry includes: biomedical material products, (biological) artificial organs, medical imaging and diagnostic equipment, medical electronic instruments and monitoring devices, modern medical treatment equipment, medical information technology, rehabilitation engineering technology and devices, tissue engineering.
(C) The relationship between biotechnology industry and pharmaceutical industry
1. Pharmaceutical biotechnology industry is the most important part of biotechnology industry
Biotechnology industry includes pharmaceutical biotechnology industry, industrial biotechnology industry, agricultural biotechnology industry and marine biotechnology industry. Among them, pharmaceutical biotechnology industry is the most important part of biotechnology industry, accounting for more than 60% of the biotechnology industry, and the application of biotechnology in pharmaceutical technology is also the most mature.
2, the proportion of pharmaceutical biotechnology industry in the pharmaceutical industry will be more and more large
At present, the output value of pharmaceutical biotechnology products (including genetically engineered drugs, vaccines, bio-diagnostic reagents, etc.) accounted for less than 10% of the proportion of the pharmaceutical industry, but due to the traditional methods of new drug development is becoming more and more difficult to develop the development of costs are rising, the success rate is getting lower and lower. As a result, 70% of the projects in the world's larger pharmaceutical companies are now developed using biotechnology. With the completion of the human genome project, it is expected that by 2010, there will be more applications of biotechnology made of brand-new drugs on the market. 21st century, the entire pharmaceutical industry is faced with the use of biotechnology to carry out the renewal and transformation.
3, the universality of the technology platform
While the sources of biological drugs and chemical drugs, traditional Chinese medicines are different, but the R & D process requires many technology platforms, such as animal centers, safety evaluation centers, pharmacology and efficacy research centers, structural testing centers, chemical pilot plant, biopharmaceutical pilot workshop, traditional Chinese medicine pilot workshop, clinical pharmacology research bases, medical device testing centers, etc. are common, in the industrialization and development of the pharmaceutical industry. It is common that in the process of industrialization and marketization, pharmaceutical biotechnology products and other pharmaceutical products face the ****same market. Therefore, combining the biotechnology industry and the pharmaceutical industry in the development together, can make full use of the common technology platform, reasonable **** enjoy the relevant resources, and promote the two industries **** the same development.